Allergan plc (AGN)


NYSE - NYSE Real Time Price. Currency in USD
253.21-0.33 (-0.13%)
At close: 4:02 PM EDT

255.00 1.79 (0.71%)
Pre-Market: 7:13 AM EDT

People also watch:
BIIBCELGVRXGILDREGN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open253.85
Prev Close253.54
Bid253.51 x 200
Ask255.00 x 200
Day's Range252.78 - 254.84
52wk Range195.50 - 322.68
1y Target EstN/A
Market Cap100.26B
P/E Ratio (ttm)24.11
Beta1.11
Volume1,562,279
Avg Vol (3m)3,093,714
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Why no other drug maker was able to close the Medivation deal
    Editor's Pick
    Nicole Sinclair2 days ago

    Why no other drug maker was able to close the Medivation deal

    On Monday, Medivation (MDVN), which owns Xtandi, confirmed it was being acquired by Pfizer (PFE) for $14 billion. This comes just months after Sanofi (SNY) approached Medivation in a hostile deal, going public with its offer and beginning a process to replace the company’s board. Sanofi lost out on its bid to Pfizer, which was willing to pay up and fold Medivation into its oncology franchise.

  • Medivation and Syngenta soar on merger news
    Editor's Pick
    Kathy Cherpelis2 days ago

    Medivation and Syngenta soar on merger news

    Medivation (MDVN) stock surged this morning. The cancer drug maker is being bought by Pfizer (PFE) in a deal valued at about $14 billion. The deal is expected to close by the end of the year and will give Pfizer access to Medivation’s cancer drug pipeline.

  • TheStreet.com1 hour ago

    Pfizer Picks Up AstraZeneca's Antibiotics Business

    The deal could be worth $1.5 billion.